Vitrolife
219,6
SEK
+0,27 %
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
+0,27%
+1,01%
+2,14%
-7,34%
-1,79%
+24,99%
-43,02%
+7,86%
+3.478,3%
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Læs mereMarkedsværdi
29,74 mia. SEK
Aktieomsætning
682,39 t SEK
Omsætning
3,61 mia.
EBIT %
21,7 %
P/E
57,94
Udbytteafkast, %
0,5 %
Finanskalender
16.4
2025
Delårsrapport Q1'25
29.4
2025
Generalforsamling '25
30.4
2025
Årligt udbytte
ViserAlle indholdstyper
Vitrolife AB (publ): Fourth quarter and full year report, 2024: A strong finish to the year
Vitrolife AB (publ): Conference call full year report 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools